Figure 1.
Logistic regression odds of 28‐day mortality for immunocompetent vs. immunocompromised patients, stratified by vaccine group: no virus immunity; first dose failure; and second dose failure. Odds adjusted for age; sex; ethnicity; socio‐economic status; and comorbidity